JUND: A Potential Drug Target and Biomarker (G3727)

Target Name: JUND

NCBI ID: G3727

JUND

JUND: A Potential Drug Target and Biomarker

JUND (JunD), a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys, is a potential drug target and biomarker for a variety of diseases. Its functions and interactions with other proteins have been the subject of intense research in recent years, and its potential as a therapeutic target continue to generate excitement among scientists and healthcare professionals.

The JUND is a transmembrane protein that plays a critical role in the regulation of cell adhesion, migration, and invasion. It is composed of an extracellular domain that is involved in cell-cell interactions and a transmembrane domain that spans the entire cell membrane. The protein is composed of two major domains: an N-terminal transmembrane domain and a C-terminal extracellular domain.

The N-terminal transmembrane domain of JUND is a protein that is involved in the regulation of cell adhesion and migration. This domain contains several important residues that are involved in the formation of the N-terminal region of the transmembrane domain. The region of JUND contains a unique structural feature, known as a long N-terminal region (LNTR), which is involved in the regulation of cell adhesion and migration.

The LNTR of JUND is a unique region that is composed of multiple coiled structures that are involved in the regulation of cell adhesion and migration. The LNTR of JUND is involved in the formation of tight junctions, which are a type of cell-cell adhesion that is critical for the regulation of tissue structure and function. The LNTR of JUND is also involved in the regulation of cell migration, which is critical for the development and maintenance of tissues and organs.

The C-terminal extracellular domain of JUND is a protein that is involved in the regulation of cell signaling and inflammation. This domain contains several important residues that are involved in the formation of the C-terminal region of the transmembrane domain. The region of JUND contains a unique structural feature, known as a cytoplasmic tail, which is involved in the regulation of cell signaling and inflammation.

The cytoplasmic tail of JUND is a unique region that is involved in the regulation of cell signaling and inflammation. The cytoplasmic tail of JUND is composed of several important residues, including a helix and a loop, which are involved in the formation of the cytoplasmic tail . The cytoplasmic tail of JUND is also involved in the regulation of cell signaling and inflammation, and is involved in the signaling pathways that are critical for the development and maintenance of tissues and organs.

JUND is involved in a variety of cellular processes that are critical for the development and maintenance of tissues and organs. Its functions and interactions with other proteins have been the subject of intense research in recent years, and its potential as a drug target and biomarker continue to generate excitement among scientists and healthcare professionals.

In conclusion, JUND is a transmembrane protein that is involved in the regulation of cell adhesion, migration, and signaling. Its functions and interactions with other proteins have been the subject of intense research in recent years, and its potential as a drug target and biomarker continue to generate excitement among scientists and healthcare professionals. Further research is needed to fully understand the functions and potential uses of JUND, and to develop effective therapies that can be used to treat a variety of diseases.

Protein Name: JunD Proto-oncogene, AP-1 Transcription Factor Subunit

Functions: Transcription factor binding AP-1 sites (PubMed:9989505). Heterodimerizes with proteins of the FOS family to form an AP-1 transcription factor complex, thereby enhancing their DNA binding activity to an AP-1 consensus sequence 3'-TGA[GC]TCA-5' and enhancing their transcriptional activity (PubMed:9989505, PubMed:28981703)

The "JUND Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about JUND comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets